Literature DB >> 8358195

The reticuloendothelial system and hepatocyte function in orthotopic liver transplantation.

T Enoki1, N Morita, K Esato.   

Abstract

The reticuloendothelial system function, especially phagocytic activity, and hepatocyte function were investigated in dogs undergoing an orthotopic liver transplantation. The donor's phagocytic index, measured by a lipid emulsion test, was higher in the Survivor group which survived more than 3 days after transplantation (0.063 +/- 0.008 vs 0.024 +/- 0.002; mean +/- standard error of the mean (SEM), P < 0.01). There was a statistically significant difference in the phagocytic index between the survivor and nonsurvivor groups. However, the hepatocyte function at an early phase after transplantation, indicated by the arterial ketone body ratio, hepaplastin test and lecithin cholesterol acyltransferase level, did not distinguish the Survivor group from the Nonsurvivor group at all. In the survivor group, the hepaplastin test and the lecithin cholesterol acyltransferase level were significantly decreased after liver transplantation, namely from 155 +/- 15% to 58 +/- 5% and from 57 +/- 12 unit/ml to 19 +/- 1 unit/ml on the 2nd day after transplantation (P < 0.01, P < 0.05), respectively. On the other hand, the reticuloendothelial system (RES) function, as estimated by the phagocytic index and serum complement activity (CH 50), demonstrated no change throughout the experimental period. The present study therefore demonstrated that the operative results might be affected by the phagocytic activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358195     DOI: 10.1007/bf00730626

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  15 in total

1.  Disturbances of reticulo-endothelial function following experimental liver transplantation.

Authors:  G Lahnborg; M Bracher; R Hickman; J Terblanche
Journal:  Eur Surg Res       Date:  1989       Impact factor: 1.745

2.  Circulatory effects of RES depression in the dog.

Authors:  E F Banaszak; J P Kampine; B A Brault; J J Smith
Journal:  Am J Physiol       Date:  1965-09

Review 3.  Physiology and physiopathology of the reticuloendothelial system.

Authors:  T M Saba
Journal:  Arch Intern Med       Date:  1970-12

4.  Metabolism during hepatic transplantation: indicators of allograft function.

Authors:  J J Fath; N L Ascher; F N Konstantinides; J Bloomer; H Sharp; J S Najarian; F B Cerra
Journal:  Surgery       Date:  1984-10       Impact factor: 3.982

5.  Changes in the reticuloendothelial phagocytic function after partial hepatectomy.

Authors:  S Arii; M Shibagaki; S Takahashi; Y Taki; N Yokoo; A Jikko; J Tanaka; Y Kamiyama; H Takasan; K Ozawa
Journal:  J Lab Clin Med       Date:  1985-06

6.  Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat.

Authors:  C M McKeown; V Edwards; M J Phillips; P R Harvey; C N Petrunka; S M Strasberg
Journal:  Transplantation       Date:  1988-08       Impact factor: 4.939

7.  Hepatic reticuloendothelial protection against bacteremia in experimental hemorrhagic shock.

Authors:  B J Pardy; R C Spencer; H A Dudley
Journal:  Surgery       Date:  1977-02       Impact factor: 3.982

8.  Short-term changes in blood ketone body ratio in the phase immediately after liver transplantation.

Authors:  Y Taki; M Ukikusa; T Morimoto; N Yokoo; K Koizumi; M Noguchi; A Tanaka; S Yamamoto; N Nitta; Y Kamiyama
Journal:  Transplantation       Date:  1987-03       Impact factor: 4.939

9.  Immediate and long-term effects of acute hepatic ischemia. II. Vascular lesions in experimental liver ischemia.

Authors:  L Grana; M Saldana; W L Donnellan; O Swenson
Journal:  Arch Surg       Date:  1968-09

10.  Significance of lecithin:cholesterol acyltransferase activity as a prognostic indicator of early allograft function in clinical liver transplantation.

Authors:  M Shimada; K Yanaga; L Makowka; S Kakizoe; D H Van Thiel; T E Starzl
Journal:  Transplantation       Date:  1989-10       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.